Regional heterogeneity of resting perfusion in hypertrophic cardiomyopathy is related to delayed contrast enhancement but not to systolic function: A PET and MRI study

Journal of Nuclear Cardiology

Volumn 13, Issue 5, 2006, Pages 660-667

  Knaapen, Paul ^a   van Dockum, Willem G ^a   Götte, Marco J W ^a   Broeze, Kimiko A ^a   Kuijer, Joost P A ^a   Zwanenburg, Jaco J M ^a   Marcus, J Tim ^a   Kok, Wouter E M ^b   van Rossum, Albert C ^a   Lammertsma, Adriaan A ^a   Visser, Frans C ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Hypertrophic cardiomyopathy; magnetic resonance imaging; myocardial blood flood; positron emission tomography

Indexed keywords

OXYGEN 15; WATER;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CALCULATION; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE PERFUSION; HEART VENTRICLE SEPTUM; HEART VENTRICLE WALL; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LINEAR REGRESSION ANALYSIS; MALE; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SYSTOLE;

ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; CONTRAST MEDIA; CORONARY CIRCULATION; FEMALE; HEART SEPTUM; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PERFUSION; POSITRON-EMISSION TOMOGRAPHY; SYSTOLE;

EID: 33747867795     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nuclcard.2006.05.018     Document Type: Article

References (36)

1. Maron B.J. Hypertrophic cardiomyopathy: a systematic review. JAMA 287 (2002) 1308-1320
2. Camici P., Chiriatti G., Lorenzoni R., Bellina R.C., Gistri R., Italiani G., et al. Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol 17 (1991) 879-886
3. Cecchi F., Olivotto I., Gistri R., Lorenzoni R., Chiriatti G., and Camici P.G. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 349 (2003) 1027-1035
4. Knaapen P., van Dockum W.G., Bondarenko O., Kok W.E., Gotte M.J., Boellaard R., et al. Delayed contrast enhancement and perfusable tissue index in hypertrophic cardiomyopathy: comparison between CMR and PET. J Nucl Med 46 (2005) 923-929
5. Nienaber C.A., Gambhir S.S., Mody F.V., Ratib O., Huang S.C., Phelps M.E., et al. Regional myocardial blood flow and glucose utilization in symptomatic patients with hypertrophic cardiomyopathy. Circulation 87 (1993) 1580-1590
6. Grover-McKay M., Schwaiger M., Krivokapich J., Perloff J.K., Phelps M.E., and Schelbert H.R. Regional myocardial blood flow and metabolism at rest in mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 13 (1989) 317-324
7. Choudhury L., Rosen S.D., Patel D., Nihoyannopoulos P., and Camici P.G. Coronary vasodilator reserve in primary and secondary left ventricular hypertrophy. A study with positron emission tomography. Eur Heart J 18 (1997) 108-116
8. Jorg-Ciopor M., Namdar M., Turina J., Jenni R., Schwitter J., Turina M., et al. Regional myocardial ischemia in hypertrophic cardiomyopathy: impact of myectomy. J Thorac Cardiovasc Surg 128 (2004) 163-169
9. Perrone-Filardi P., Bacharach S.L., Dilsizian V., Panza J.A., Maurea S., and Bonow R.O. Regional systolic function, myocardial blood flow and glucose uptake at rest in hypertrophic cardiomyopathy. Am J Cardiol 72 (1993) 199-204
10. Kramer C.M., Reichek N., Ferrari V.A., Theobald T., Dawson J., and Axel L. Regional heterogeneity of function in hypertrophic cardiomyopathy. Circulation 90 (1994) 186-194
11. Maier S.E., Fischer S.E., McKinnon G.C., Hess O.M., Krayenbuehl H.P., and Boesiger P. Evaluation of left ventricular segmental wall motion in hypertrophic cardiomyopathy with myocardial tagging. Circulation 86 (1992) 1919-1928
12. Choudhury L., Mahrholdt H., Wagner A., Choi K.M., Elliott M.D., Klocke F.J., et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 40 (2002) 2156-2164
13. Moon J.C., McKenna W.J., McCrohon J.A., Elliott P.M., Smith G.C., and Pennell D.J. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 41 (2003) 1561-1567
14. van Dockum W.G., ten Cate F.J., ten Berg J.M., Beek A.M., Twisk J.W., Vos J., et al. Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging. J Am Coll Cardiol 43 (2004) 27-34
15. Knaapen P., Boellaard R., Gotte M.J., Dijkmans P.A., Van Campen L.M., De Cock C.C., et al. Perfusable tissue index as a potential marker of fibrosis in patients with idiopathic dilated cardiomyopathy. J Nucl Med 45 (2004) 1299-1304
16. Zerhouni E.A., Parish D.M., Rogers W.J., Yang A., and Shapiro E.P. Human heart: tagging with MR imaging-a method for noninvasive assessment of myocardial motion. Radiology 169 (1988) 59-63
17. Iida H., Kanno I., Takahashi A., Miura S., Murakami M., Takahashi K., et al. Measurement of absolute myocardial blood flow with H215O and dynamic positron-emission tomography. Strategy for quantification in relation to the partial-volume effect. Circulation 78 (1988) 104-115
18. Hermansen F., Rosen S.D., Fath-Ordoubadi F., Kooner J.S., Clark J.C., Camici P.G., et al. Measurement of myocardial blood flow with oxygen-15 labelled water: comparison of different administration protocols. Eur J Nucl Med 25 (1998) 751-759
19. van Dockum W.G., Beek A.M., ten Cate F.J., ten Berg J.M., Bondarenko O., Gotte M.J., et al. Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic obstructive cardiomyopathy. Circulation 111 (2005) 2503-2508
20. Kaufmann P.A., Gnecchi-Ruscone T., Yap J.T., Rimoldi O., and Camici P.G. Assessment of the reproducibility of baseline and hyperemic myocardial blood flow measurements with 15O-labeled water and PET. J Nucl Med 40 (1999) 1848-1856
21. Axel L., Goncalves R.C., and Bloomgarden D. Regional heart wall motion: two-dimensional analysis and functional imaging with MR imaging. Radiology 183 (1992) 745-750
22. Czernin J., Porenta G., Brunken R., Krivokapich J., Chen K., Bennett R., et al. Regional blood flow, oxidative metabolism, and glucose utilization in patients with recent myocardial infarction. Circulation 88 (1993) 884-895
23. Braunwald E. Control of myocardial oxygen consumption: physiologic and clinical considerations. Am J Cardiol 27 (1971) 416-432
24. Ishiwata S., Maruno H., Senda M., Toyama H., Nishiyama S., and Seki A. Mechanical efficiency in hypertrophic cardiomyopathy assessed by positron emission tomography with carbon 11 acetate. Am Heart J 133 (1997) 497-503
25. Marinho N.V., Keogh B.E., Costa D.C., Lammerstma A.A., Ell P.J., and Camici P.G. Pathophysiology of chronic left ventricular dysfunction. New insights from the measurement of absolute myocardial blood flow and glucose utilization. Circulation 93 (1996) 737-744
26. Varnava A.M., Elliott P.M., Sharma S., McKenna W.J., and Davies M.J. Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. Heart 84 (2000) 476-482
27. Moon J.C.C., Reed E., Sheppard M.N., Elkington A.G., Ho S., Burke M., et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 43 (2004) 2260-2264
28. Papavassiliu T., Schnabel P., Schroder M., and Borggrefe M. CMR scarring in a patient with hypertrophic cardiomyopathy correlates well with histological findings of fibrosis. Eur Heart J 26 (2005) 2395
29. Aso H., Takeda K., Ito T., Shiraishi T., Matsumura K., and Nakagawa T. Assessment of myocardial fibrosis in cardiomyopathic hamsters with gadolinium-DTPA enhanced magnetic resonance imaging. Invest Radiol 33 (1998) 22-32
30. Basso C., Thiene G., Corrado D., Buja G., Melacini P., and Nava A. Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia. Hum Pathol 31 (2000) 988-998
31. Lamke G.T., Allen R.D., Edwards W.D., Tazelaar H.D., and Danielson G.K. Surgical pathology of subaortic septal myectomy associated with hypertrophic cardiomyopathy. A study of 204 cases (1996-2000). Cardiovasc Pathol 12 (2003) 149-158
32. Geisterfer-Lowrance A.A., Christe M., Conner D.A., Ingwall J.S., Schoen F.J., Seidman C.E., et al. A mouse model of familial hypertrophic cardiomyopathy. Science 272 (1996) 731-734
33. Melacini P., Corbetti F., Bobbo F., and Cacciavillani F. Detection of myocardial fibrosis, edema and hypoperfusion in hypertrophic cardiomyopathy by magnetic resonance imaging. [abstract]. Circulation Supplements (2004)
34. Kim R.J., Chen E.L., Lima J.A., and Judd R.M. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 94 (1996) 3318-3326
35. Uren N.G., Melin J.A., De Bruyne B., Wijns W., Baudhuin T., and Camici P.G. Relation between myocardial blood flow and the severity of coronary-artery stenosis. N Engl J Med 330 (1994) 1782-1788
36. Di Carli M., Czernin J., Hoh C.K., Gerbaudo V.H., Brunken R.C., Huang S.C., et al. Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease. Circulation 91 (1995) 1944-1951